 Oramed Pharmaceuticals Inc. Nasdaq: ORMP TASE: ORMP a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, today announced positive feedback from its initial End-of-Phase 2 EoP2 meeting with the U.S. Food and Drug Administration FDA to discuss Chemistry Manufacturing and Control CMC of its lead oral insulin capsule ORMD-0801. 